Table 3 Pyrosequencing primer used for mutation profiling in exon 5 and for validation of mutations in exon 4, 7, and 8

From: Estrogen receptor (ESR1) mutation in bone metastases from breast cancer

ESR1 exon 4 for

5′-GGAGACATGAGAGCTGCCAACC-3′

ESR1 exon 4 rev

5′-AATAGAGTATCGGGGGCTCAGCA-3′

ESR1 exon 4 pyroseq for

5′-ATGATCAAACGCTCTAAG-3′

ESR1 exon 4 pyroseq rev

5′-AAGGCCAGGCTGTTC-3′

ESR1 exon 5 for

5′-GTTTTCAGGCTTTGTGGATTTGAC-3′

ESR1 exon 5 rev

5′-ACGAGACCAATCATCAGGATCTCT-3′

ESR1 exon 5 pyroseq for

5′-TCTAGCCAGGCACATT-3′

ESR1 exon 5 pyroseq rev

5′-ATCAGGTCCACCTTCTA-3′

ESR1 exon 7 for

5′-TCTCTGCGCATTCAGGAGTGT-3′

ESR1 exon 7 rev

5′-TGCCTTGGCCATCAGGTG-3′

ESR1 exon 7 pyroseq for

5′-GGAGTGTACACATTTCTG-3′

ESR1 exon 7 pyroseq rev

5′-AGAGACTTCAGGGTGCTGG-3′

ESR1 exon 8 for

5′-TGGAGCATCTGTACAGCATGAAG-3′

ESR1 exon 8 rev

5′-GGCGTCCAGCATCTCCAG-3′

ESR1 exon 8 pyroseq for

5′-AAGAACGTGGTGCCCC-3′

ESR1 exon 8 pyroseq rev

5′-GCATCTCCAGCAGCAG-3′